Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Paasch U et al. - Male hypogonadism is characterised by decreased testicular function, especially testosterone deficiency. Its prevalence increases with age but may be acquired in all stages of life if it is not inborn. In patients with prostate cancer, breast cancer, polycythemia, severe heart failure, obstruction of the lower urinary tract, or untreated sleep apnoea, testosterone treatment must be avoided.

Related Articles

Safety and efficacy of testosterone gel in the treatment of male hypogonadism
Clinical Interventions in Aging, 10/12/09    Relevance Score: 81%

Testosterone therapy and prostate carcinoma
Current Urology Reports, 11/17/09    Relevance Score: 80%

Is androgen therapy indicated for aging men?
Sexuality, Reproduction & Menopause, 10/05/09    Relevance Score: 80%

NIH-Supported Trial to Study Testosterone Therapy in Older Men
MedLinePlus, 11/04/09    Relevance Score: 68%

Testosterone supplementation: For whom and when?
Sexuality, Reproduction & Menopause, 10/08/09    Relevance Score: 68%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address